Yang et al. found that miR-19b-1 reverses ischemia-induced heart failure through inhibiting cardiomyocyte apoptosis and targeting Bcl2-like 11/BIM (a pro-apoptotic gene of the Bcl-2 family) (Yang et al. 2019). The gene discussed is BCL2; the disease is ischemia.